1887
Volume 2016, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Misoprostol is a synthetic prostaglandin E1 that induces cervical effacement and uterine contractions at all gestational ages, thus facilitating uterine evacuation and pregnancy termination. Successful medical evacuation of spontaneous miscarriage with minimal adverse effects can be performed using misoprostol-only regimen if given as indicated and if the administered dose, frequency of the dosage, and number of total doses are appropriate. To conduct a drug use evaluation by investigating indications, appropriateness of dosing, and clinical outcome of misoprostol-only regimen when used for medical evacuation of spontaneous miscarriage at the Women's Hospital in Doha, Qatar. A retrospective descriptive drug use evaluation was conducted on women with spontaneous miscarriage who received misoprostol for medical evacuation during August 2013. The current practice at the Women's Hospital was compared with the recommendation from the World Health Organization (WHO). Patients were stratified into three groups based on weeks of amenorrhea. A total of 107 patients received misoprostol during August 2013, of which 33 (31%) were included in the study. In these patients, the main indication for misoprostol use was missed miscarriage (54.5%). In the group of patients at ≤ 9 weeks of gestation, 80% received an initial dose of 800 μg, 80% received frequency within the WHO recommendation, and the majority had surgical evacuation (80%). In the group of patients at 10–12 weeks of gestation, more than 80% received an initial dose of 800 μg, 6% received frequency within the WHO recommendation, and more than 75% had successful medical evacuation. In the group of patients at 13–22 weeks of gestation, more than 80% received an initial dose of 400 μg, more than 80% received frequency within the WHO recommendation, and 54% had successful medical evacuation. Overall, more than 70% of the patients received ≤ 3 total doses of misoprostol and more than 60% had successful medical evacuation as a clinical outcome. Despite the current practice at the Women's Hospital not always being in accordance with the WHO recommendation, successful medical evacuation was achieved in most patients.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2016.5
2016-06-15
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2016/1/qmj.2016.5.html?itemId=/content/journals/10.5339/qmj.2016.5&mimeType=html&fmt=ahah

References

  1. [1]. Tulandi T., , Al-Fozan HM. . Spontaneous Abortion: Management. UpToDate [Internet]. . 23 October 2013, available from: http://www.uptodate.com/contents/spontaneous-abortion-management? Cited on 6 November 2013 .
  2. [2]. Kulsum   SU., , Khatun   S., , Tabib   SM. . Use of misoprostol in pregnancy: A review article. . MED Today . 2010; ;22: : 94– 98 .
    [Google Scholar]
  3. [3]. Griebel   CP., , Halvorsen   J., , Golemon   TB., , Day   AA. . Management of spontaneous abortion. . Am Fam Physician . 2005; ;72: : 1243– 1250 .
    [Google Scholar]
  4. [4]. South Australian Perinatal Practice Guidelines . First Trimester Medical and Surgical Termination of Pregnancy. Department of Health. . 29 April 2013, available from: http://www.sahealth.sa.gov.au/wps/wcm/connect/. Cited on 1 December 2013 .
  5. [5]. Fernandez   MM., , Coeytaux   F., , de León   RG., , Harrison   DL. . Assessing the global availability of misoprostol. . Int J Gynaecol Obstet . 2009; ;105: : 180– 186 .
    [Google Scholar]
  6. [6]. Nahar   K., , Chowdhury   S., , Shamim   S., , Nasrin   B., , Hossain   F., , Begum   N. . Role of misoprostol in missed abortion. . Bangladesh J Obstet Gynaecol . 2011; ;26: : 92– 99 .
    [Google Scholar]
  7. [7]. Faúndes   A., , Fiala   C., , Tang   OS., , Velasco   A. . Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. . Int J Gynaecol Obstet . 2007; ;99: : S172– S177 .
    [Google Scholar]
  8. [8]. Ho   PC., , Blumenthal   PD., , Gemzell-Danielsson   K., , Gómez Ponce de León   R., , Mittal   S., , Tang   OS. . Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. . Int J Gynaecol Obstet . 2007; ;99: : S178– S181 .
    [Google Scholar]
  9. [9]. Shaw   D. . Misoprostol for reproductive health: Dosage recommendations. . Int J Gynaecol Obstet . 2007; ;99: : S155 .
    [Google Scholar]
  10. [10]. Tang   J., , Kapp   N., , Dragoman   M., , de Souza   JP. . WHO recommendations for misoprostol use for obstetric and gynecologic indications. . Int J Gynaecol Obstet . 2013; ;121: : 186– 189 .
    [Google Scholar]
  11. [11]. Naz   S., , Sultana   N. . Role of misoprostol for therapeutic termination of pregnancy from 10–28 weeks of gestation. . J Pak Med Assoc . 2007; ;57: : 129– 132 .
    [Google Scholar]
  12. [12]. Holloway K., , Green T. . Drug and therapeutic committee: A practical guide. WHO [Internet]. . 2003, from: http://apps.who.int/iris/handle/10665/68553. Cited on 11 November 2013 .
  13. [13]. Gouk   EV., , Lincoln   K., , Khair   A., , Haslock   J., , Knight   J., , Cruickshank   DJ. . Medical termination of pregnancy at 63 to 83 days gestation. . Br J Obstet Gynaecol . 1999; ;106: : 535– 539 .
    [Google Scholar]
  14. [14]. Institute of Obstetricians and Gynecologists . Clinical Practice Guideline: Management of Early Pregnancy Miscarriage. . Royal College of Physicians of Ireland April 2014;1:1–24 .
  15. [15]. Creinin   MD. . Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion. . Contraception . 2000; ;62: : 117– 124 .
    [Google Scholar]
  16. [16]. Munthali   J., , Moodley   J. . The use of misoprostol for mid-trimester therapeutic termination of pregnancy. . Trop Doct . 2001; ;31: : 157– 161 .
    [Google Scholar]
  17. [17]. Herabutya   Y., , Chanrachakul   B., , Punyavachira   P. . Second trimester pregnancy termination: A comparison of 600 and 800 micrograms of intravaginal misoprostol. . J Obstet Gynaecol Res . 2001; ;27: : 125– 128 .
    [Google Scholar]
  18. [18]. Sirimai   K., , Kiriwat   O., , Neungton   S., , Suvanichchati   S. . Misoprostol use for therapeutic abortion in Siriraj Hospital: The year 2000. . J Med Assoc Thai . 2002; ;85: : 416– 423 .
    [Google Scholar]
  19. [19]. Ireland   LD., , Gatter   M., , Chen   AY. . Medical compared with surgical abortion for effective pregnancy termination in the first trimester. . Obstet Gynecol . 2015; ;126: : 22– 28 .
    [Google Scholar]
  20. [20]. Choy-Hee   L., , Raynor   BD. . Misoprostol induction of labor among women with a history of cesarean delivery. . Am J Obstet Gynecol . 2001; ;184: : 1115– 1117 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2016.5
Loading
/content/journals/10.5339/qmj.2016.5
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): drug use evaluation , medical evacuation , misoprostol , Qatar and spontaneous miscarriage
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error